title: [Study of autoantibodies against the G-protein-coupled beta 2- and alpha 1-adrenergic and AT1 receptors in patients with primary hypertension].
abstract: OBJECTIVE
  To determine whether autoantibodies against the cardiac G-protein-coupled beta 2- and alpha 1-adrenergic and AT1 receptors are related to patients with primary hypertension.
  
  
  METHODS
  Synthetic peptides corresponding to amino acid sequences of the second extracellular loops of the beta 2- and alpha 1-adrenergic and AT1 receptors were respectively used as antigens to screen sera from patients with hypertensive heart diseases (n = 50) as well as simple hypertension (n = 40) and healthy blood donors (n = 40) using ELISA test.
  
  
  RESULTS
  The positive ratio of autoantibodies against beta 2 and alpha 1 and AT1 receptors in patients with hypertensive heart diseases were significantly higher than patients with simple hypertension and healthy donors. The geometric mean titers of autoantibodies against beta 2- and alpha 1-adrenergic and AT1 receptors had no difference between the patients with hypertensive heart diseases and the patients with simple hypertension, but the geometric mean titers of two groups were higher than healthy donors. In the patients with hypertensive heart diseases, 81.0% of the patients with autoantibodies against beta 2-adrenergic receptor had autoantibodies against alpha 1-adrenergic receptor and 76.2% had autoantibodies against AT1 receptors. The percent of the autoantibodies against three receptors in patients with hypertensive heart diseases were 52.4%.
  
  
  CONCLUSIONS
  Autoantibodies against beta 2- and alpha 1-adrenergic and AT1 receptors play an important role in the pathophysiological changes of primary hypertension, and may participate myocardial and vessel remodeling.
authors.affiliation: Capital Medical University, Beijing Chao Yang Hospital, Beijing 100020, China. lin07371@sina.com
authors.forename: Lin
authors.initials: L
authors.lastname: Zhang
authors.forename: Liang
authors.initials: L
authors.lastname: Cui
authors.forename: Guo-bin
authors.initials: GB
authors.lastname: Miao
authors.forename: Wen-shu
authors.initials: WS
authors.lastname: Zhao
authors.forename: Shu-yan
authors.initials: SY
authors.lastname: Wang
authors.forename: Xiu-lan
authors.initials: XL
authors.lastname: Liu
mesh_terms: D000328:Adult; D000368:Aged; D001323:Autoantibodies / Q000097:blood*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D044140:Receptor, Angiotensin, Type 1 / Q000276:immunology*; D018340:Receptors, Adrenergic, alpha-1 / Q000276:immunology; D018343:Receptors, Adrenergic, beta-2 / Q000276:immunology*
chemical_list: D001323:Autoantibodies; D044140:Receptor, Angiotensin, Type 1; D018340:Receptors, Adrenergic, alpha-1; D018343:Receptors, Adrenergic, beta-2